PT Armidian Karyatama Tbk

    PT Armidian Karyatama Tbk

    IIDX:ARMY
    50.00
    IDR
    0.00
    (0.00%)
    67.55P/E

    Share Statistics

    As of September 30, 2021, PT Armidian Karyatama Tbk has 9.01B shares outstanding.

    Shares Outstanding9.01B

    Valuation Ratios

    As of September 30, 2021, PT Armidian Karyatama Tbk trades at a trailing price-to-earnings ratio of 67.55. The price-to-sales ratio is 6.26, and the price-to-book ratio stands at 0.31.

    PE Ratio67.55
    PS Ratio6.26
    PB Ratio0.31
    P/TBV Ratio0.31
    P/FCF Ratio11.42

    Enterprise Valuation

    As of September 30, 2021, PT Armidian Karyatama Tbk trades at an EV/EBITDA multiple of 39.20 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 7.47 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 39.20 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. PT Armidian Karyatama Tbk trades at an EV/FCF ratio of 12.71, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

    EV / Sales7.47
    EV / EBITDA39.20
    EV / EBIT39.20
    EV / FCF12.71

    Financial Position

    As of September 30, 2021, PT Armidian Karyatama Tbk maintains a current ratio of 5.72, meaning it holds 5.7x the short-term assets needed to cover near-term liabilities.

    Current Ratio5.72
    Quick Ratio0.11
    Interest Coverage4.83

    Financial Efficiency

    Over the twelve months ended September 30, 2021, PT Armidian Karyatama Tbk posted a return on equity (ROE) of 0.38, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 0.74 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 0.32, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 0.51, useful for judging operating efficiency across full business cycles. Inventory turnover of 0.13 indicates how many times PT Armidian Karyatama Tbk sells and replaces its inventory over a year, a key working capital efficiency ratio.

    Return on Equity (ROE)0.38
    Return on Assets (ROA)0.32
    Return on Invested Capital (ROIC)0.74
    Return on Capital Employed (ROCE)0.51
    Inventory Turnover0.13

    Stock Price Statistics

    IDR

    As of the close on May 23, 2023, PT Armidian Karyatama Tbk's stock has gained approximately 0.00% over the past 52 weeks. The 50-day moving average sits at 50.00, while the 200-day moving average is 50.00.

    50-Day Moving Average50.00
    200-Day Moving Average50.00

    Margins

    Over the twelve months ended September 30, 2021, PT Armidian Karyatama Tbk posted a gross margin of 50.23, reflecting its pricing power and cost economics. The operating margin of 19.05 and net profit margin of 9.27 provide insight into operational efficiency.

    Gross Margin50.23
    Operating Margin19.05
    Pretax Margin9.27
    Profit Margin9.27
    EBITDA Margin19.05

    Dividends & Yields

    These figures cover the twelve months ended September 30, 2021. Free cash flow yield stands at 8.75, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -4.04, meaning PT Armidian Karyatama Tbk raised more capital through share issuance and new debt than it returned via dividends and buybacks.

    Shareholder Yield-4.04
    FCF Yield8.75

    Scores

    As of September 30, 2021, PT Armidian Karyatama Tbk has an Altman Z-Score of 1.46, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

    Altman Z-Score1.46